Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout

NCT00111657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gout

Interventions

BIOLOGICAL: Pegloticase

Sponsor

John Sundy

Collaborators

[object Object]